July/August 2011 Vol 11 No 6 www.drug-dev.com
IN THIS
ISSUE
INTERVIEW WITH
TYRX’S
PRESIDENT & CEO
ROBERT WHITE
The New
Phase I
18
Derek Hennecke
Transdermal
Update
22
Cindy H. Dubin
Revenue Contract
Management
42
James Burke
Richard Butler
Biosimilars
Market
57
Katheryn Symank
FEATURING
The science & business of drug development in specialty pharma, biotechnology, and drug delivery
Jeffrey
Purnell, PhD
Advanced Adhesive
Technologies Deliver
Enhanced
Performance
Capabilities to
Transdermal Product
Designs
Srikanth
Kakumanu, PhD
Adaptive Focused
Acoustics for the
Formulation of
Suspensions &
Nano-Suspensions
Erik
Wittenzellner
Delivering Quality in
Personal Dosimetry
Devices
Multiple
Sclerosis
65
Getaw W. Hassen, MD, PhD
Retinal
Diseases
70
Steven Bettis
